Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-11-30
著者
-
Sowa Hideaki
Lilly Res. Laboratories Japan Eli Lilly Japan Kk
-
Hamaya Etsuro
Lilly Research Laboratories Eli Lilly And Company
-
GOTO Wakana
Lilly Research Laboratories Japan, Development Center of Excellence Asia Pacific, Eli Lilly Japan K. K.
-
MIYAUCHI Akimitsu
Miyauchi Medical Center
-
SOWA Hideaki
Lilly Research Laboratories Japan, Development Center of Excellence, Eli Lilly Japan K. K.
-
IIKUNI Noriko
Lilly Bio-Medicines, Eli Lilly and Company
-
YOKOYAMA Shunji
Drug Safety Division, Chugai Pharmaceutical Co., Ltd
-
NIHOJIMA Shigeru
Drug Safety Division, Chugai Pharmaceutical Co., Ltd
-
TAKETSUNA Masanori
Lilly Research Laboratories Japan, Development Center of Excellence Asia Pacific, Eli Lilly Japan K. K.
関連論文
- Exenatide Exhibits Dose-Dependent Effects on Glycemic Control over 12 Weeks in Japanese Patients with Suboptimally Controlled Type 2 Diabetes
- Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
- Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia
- Effects of teriparatide in Japanese and non-Japanese populations : bridging findings on pharmacokinetics and efficacy
- Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance
- Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide : a meta-analysis